
Avlyn Pharma Private Limited
About Avlyn Pharma Private Limited
Data last updated:
Avlyn Pharma Private Limited is a private limited company based in Panvel, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52310MH2016PTC272019. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sureshchand Sarvajeet Yadav and Pankaj Kumar Yadava.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Panvel, Maharashtra.
As per the financials filed for FY 2020, the company reported a revenue of ₹4.19 Lakh, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹5.73 Lakh (net margin -136.7%) and EBITDA of -₹5.73 Lakh (EBITDA margin -136.7%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Avlyn Pharma Private Limited's registered office is in Panvel, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressChintamani Apt Mohini Properties Pl – 421/1B Takka/ Sh, Op No.2, Panvel, Maharashtra, India – 410206
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Avlyn Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avlyn Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Avlyn Pharma Private Limited, buy the company report.
Financials of Avlyn Pharma Private Limited
FY 2020 filings availableAvlyn Pharma Private Limited reported revenue of ₹4.19 Lakh (down 68% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 37% over three years, including a 68% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹4.19 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.73 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.73 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -136.7% | ||||
| Net Profit Margin | -136.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avlyn Pharma Private Limited, buy the company report.
Board of directors of Avlyn Pharma Private Limited
Avlyn Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sureshchand Sarvajeet Yadav | Director | 13 Jan 2016 | 10 Years 9 Months | Current |
| Pankaj Kumar Yadava | Additional Director | 13 Oct 2017 | 9 Years 0 Months | Current |
Peer comparison
Avlyn Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avot Pharmaceuticals Private Limited | ₹4.21 Lakh (FY 2021) | -73.0% | Baddi, Himachal Pradesh, India | |||
| Avin Life Sciences Private Limited | ₹4.2 Lakh (FY 2020) | -42.0% | Dehradun, Uttarakhand, India | |||
| Avlyn Pharma Private Limitedthis company | ₹4.19 Lakh (FY 2020) | -₹5.73 Lakh | -136.7% | -68.0% | Panvel, Maharashtra, India | |
| Grosent Pharmaceuticals Private Limited | ₹4.16 Lakh (FY 2020) | Thane, Maharashtra, India |
To see the full peer comparison of Avlyn Pharma Private Limited, buy the company report.
Auditor
Avlyn Pharma Private Limited is audited by A T UPADHYE & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A T UPADHYE & CO | FY 2018 | 111175W |
Shareholding
The shareholding of Avlyn Pharma Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Avlyn Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Avlyn Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avlyn Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Avlyn Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Avlyn Pharma Private Limited, buy the company report.
Recent activity
Avlyn Pharma Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Lokendraprasad Chandradev Ojha ceased to be Director on 13 Oct 2017.
Frequently asked questions
Avlyn Pharma is an active private limited company based in Panvel, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 January 2016 (10+ years old) and is registered under CIN U52310MH2016PTC272019.
Avlyn Pharma has 2 current directors:
- Sureshchand Sarvajeet Yadav - Director
- Pankaj Kumar Yadava - Additional Director
The latest financial statements of Avlyn Pharma on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2016 are in the company report.
No. Avlyn Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Avlyn Pharma is U52310MH2016PTC272019. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avlyn Pharma was incorporated on 13 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Avlyn Pharma by revenue are Avot Pharmaceuticals Private Limited, Avin Life Sciences Private Limited, Grosent Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Lokendraprasad Chandradev Ojha ceased to be Director on 13 Oct 2017. Pankaj Kumar Yadava was appointed as Additional Director on 13 Oct 2017. Sureshchand Sarvajeet Yadav was appointed as Director on 13 Jan 2016.
The registered office of Avlyn Pharma is at Chintamani Apt Mohini Properties Pl – 4211B Takka Sh, Op No.2, Panvel, Maharashtra, India – 410206.
Avlyn Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Avlyn Pharma is compliant as of 12 July 2026. The company is actively filing with the Registrar of Companies.